Redox-responsive polymeric nanocarriers for targeted delivery of bruceantin to pancreatic cancer
Year: 2026
Type: article
Abstract: ). Biodistribution studies in an orthotopic pancreatic cancer murine model revealed substantial accumulation of LHRH-targeted nanoparticles primarily in tumors following systemic administration, with minimal hepatic deposition. Furthermore, BCT-loaded nanoplatforms reduced tumor growth by ∼72.4% relative to controls, with no detectable adverse effects. Collectively, this work highlights the potential of LHRH-functionalized nanoplatforms as a promising strategy for the targeted treatment of pancreatic cancer with BCT, offering enhanced therapeutic efficacy with minimal systemic toxicity and paving the way for future clinical translation of this natural product.
Source: Nanoscale
DOI: 10.1039/d6nr00636a
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
Awards: Development of magnetic hyperthermia for the systemic treatment of endometriosis, Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic Hyperthermia, Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia, Nanoparticle-mediated placental imaging and magnetic hyperthermia for management of ectopic pregnancy
OpenAlex ID: W7196948794
